|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
Bernstein Liebhard LLP today announced that a lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of a class (the “Class”) of investors who purchased Subaye,...
The Briscoe Law Firm, PLLC, founded by a former state prosecutor and enforcement attorney for the United States Securities and Exchange Commission, and the law firm of Powers Taylor, LLP are investigating...
Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights; consumer rights; and enforcement of federal antitrust laws, is investigating potential wrongdoing at Subaye, Inc.
The Rosen Law Firm, P.A.
Missing regulations and broken ownership structures imperil U.S.-based investors' portfolios.
Shares of Subaye (Nasdaq:SBAY) were gapping down Tuesday morning with an open price 39.9% lower than Monday's closing price. The stock closed at $5.92 yesterday and opened today's trading at $3.56.
Subaye shares were plunging in premarket trading Tuesday after the company announced the resignation of its chief financial officer.
Impax Laboratories and Subaye were among stocks seeing heavy trading interest in Monday's after-hours action.
Shares of Subaye (Nasdaq:SBAY) were gapping down Wednesday morning with an open price 12.4% lower than Tuesday's closing price. The stock closed at $8.20 yesterday and opened today's trading at $7.18.
Despite recent controversy about U.S.-listed China stocks, the group in aggregate has risen smartly over the past month.
Despite the SEC probe and negative press on China stocks, these three may have significant potential in first-half 2011.
The potential uplisting of Biostar has created some misconceptions about how a stock makes its way to a major exchange.
Although stock prices are unpredictable, stock fundamentals and company performance are often very predictable.